Nanopore-based molecular diagnostics and integrated micro-/nanofluidic–microelectronic platforms using bioinformatics, AI and molecular simulation to enable earlier, more targeted detection and treatment in personalized medicine (e.g., cancer, diabetes, cardiovascular, mental and neurodegenerative diseases).